5 Results for "

HIV viral core

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "HIV viral core" in MCE Product Catalog:

Cat. No.: HY-105148
CAS No.: 174391-92-5
Synonyms: DMP-450
Target:  

HIV Protease HIV

Research Areas:  

Infection

Mozenavir (DMP-450) is an orally active cyclic urea HIV-1 protease inhibitor with an IC50 of 76 nM. Mozenavir inhibits replication by targeting viral protease, blocks viral polyprotein processing, and induces the production of core-uncondensed, immature, non-infectious viral particles in chronically infected cells. Mozenavir is applicable to research related to HIV infection .
loading...
    loading...
Cat. No.: HY-120764
CAS No.: 1207481-21-7
Target:  

HIV

Research Areas:  

Infection

PF-46396 is a potent HIV-1 inhibitor with an EC50 value of 0.206 µM. PF-46396 shows antiviral activity. PF-46396 inhibits the processing of capsid (CA)/spacer peptide 1 (SP1) (p25) Gag precursor proteins and blocks maturation of the viral core particle .
loading...
    loading...
Cat. No.: HY-P10653
CAS No.: 811418-15-2
Target:  

HCV HIV

Research Areas:  

Infection

C5A is a microbicidal peptide, anti-hepatitis C virus (HCV), and anti-HIV agent. C5A disrupts the membrane integrity of the HIV virion as well as the integrity of the conical capsid core that surrounds the viral genome. C5A inhibits in vitro infectivity of a broad range of primary HIV isolates in various primary target cells. C5A protects mice against vaginal and rectal HIV challenges .
loading...
    loading...
Cat. No.: HY-182277
CAS No.: 1392118-63-6
Target:  

HIV Integrase HIV

Research Areas:  

Infection

GSK-1264 is an HIV-1 integrase inhibitor. GSK-1264 binds to a site spanning the HIV-1 integrase catalytic core domain and C-terminal domain, mediates formation of an open polymer of HIV-1 integrase dimers via inhibitor-bridged contacts between adjacent dimers. GSK-1264 disrupts late-stage HIV replication by interfering with viral particle assembly. GSK-1264 stimulates inappropriate polymerization of HIV-1 integrase. GSK-1264 can be used for the research of HIV infection .
loading...
    loading...
Cat. No.: HY-182514
CAS No.: 748785-70-8
Target:  

HIV hnRNP

Research Areas:  

Infection Cancer

BMMP is an anti-HIV-1 agent and hnRNP M modulator. BMMP modulates hnRNP M function to suppress CD44 mRNA expression. BMMP induces abnormal uncoating of the HIV viral core at the post-entry step. BMMP suppresses migration of TGF-β-stimulated lung carcinoma cells. BMMP suppresses HIV-1 reverse transcription and replication without inhibiting virion release. BMMP exerts anti-HIV-1 activity via a mechanism distinct from CA protein-binding heterocyclic compounds. BMMP can be used for the research of human immunodeficiency virus infection and non-small cell lung cancer .
loading...
    loading...